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Abstract 
 
An unexpected azeto[2,3-c]quinolizinedione has been isolated during synthetic studies on 
the base catalyzed condensation of ethyl 6-methylpyridin-2(1H)-on-1-ylacetate with benzil. 
Closure of a fused four-membered azetidinone ring occurred when potassium 
hexamethyldisilazide was employed as the base. The structure of the product was 
confirmed by synchrotron X-ray crystallography. A possible mechanism for the formation of 
the product is considered. 
 
Introduction 
 
4H-Quinolizin-4-one1 1 and 2H-quinolizin-2-one2 2 (Figure 1) represent neutral carbonyl-
bearing derivatives of the quinolizinium ring3 system 3, a bridgehead azanaphthalene. 
Such compounds have potential application in drug development as alternatives to 
quinoline 4 and isoquinoline 5 derivatives, which are much exploited in medicinal 
chemistry.4 
 
 
Figure 1: Azanaphthalene rings employed in medicinal chemistry 
 
A number of quinolizin-4-one based drug candidates have been developed,5,6 but 
considerable scope remains to employ this ring as a central building block in drug 
discovery. As part of a project to develop synthetic routes to quinolizin-4-ones 1 as new 
drug scaffolds we investigated the deprotonation of 1(N)-alkyl-6-methylpyridin-2-ones and 
the possibility of condensation with 1,2-dicarbonyl compounds to form the second fused 
pyridine ring. In this paper we report the unexpected formation of an azeto[2,3-
c]quinolizinedione that was isolated from the reaction of 6 with benzil 7a (Scheme 1). 
 
  
Results and Discussion 
 
During a study on the deprotonation of pyridone 6 (Scheme 1) with potassium 
hexamethyldisilazide (KHMDS), we investigated the reaction with benzil 7a as a 1,2-bis 
electrophile, using 2.75 equivalents of the base, with the expectation of performing a 
Westphal-type condensation7 to form quinazolin-4-one 8. However the reaction formed a 
complex mixture of products, and none of the expected quinolizinone ester 8 was obtained 
after chromatographic separation of the crude reaction mixture.8 Surprisingly, the only 
compound that could be obtained pure was the fused azetidinone 9, in which the 
quinolizin-4-one ring skeleton had formed, but which bore a fused 4-membered lactam 
ring. 
 
 
Scheme 1: Reaction of activated pyridone 6 with benzil 
 
The presence of a 4-membered lactam ring in the molecule was strongly suggested by a 
combination of IR and NMR spectroscopy. In particular, the IR spectrum showed a signal 
at 1776 cm–1 indicating the presence of a small ring carbonyl group. The 1H NMR 
spectrum showed an exchangeable signal at δ 10.29 ppm consistent with an NH and a 
methine singlet at δ 5.86 ppm (H-9a). The absence of signals for an ethyl ester indicated 
that this group had been transformed. The 13C NMR spectrum exhibited a signal at δ 68.1 
ppm consistent with a saturated CH (C-9a) and two carbonyl signals at δ 164.7 and 160.5 
ppm. The structure of the molecule was verified by single crystal X-ray diffraction analysis, 
confirming the presence of the 4-membered lactam, which was shown to exist as a mono-
ethanol solvate 9·EtOH (Figure 2). 
 
 
Figure 2: X-ray crystal structure of azeto[2,3-c]quinolizinedione, 9·EtOH, showing the 
ethanol-inserted hydrogen-bonds between pairs of molecules of 9. 
 
Yellow crystals with a plate morphology were formed after slow evaporation of an ethanolic 
solution of 9. Due to their small size and weak diffracting power, data were collected using 
synchrotron radiation.9 The molecules were found to form head-to-tail R44(18) H-bonded 
pairs via inserted ethanol molecules.10-12 The hydrogen bond geometry is given in Table 1.  
 
Table 1. Hydrogen-bond geometry (Å, º) for 9·EtOH 
  D—H···A D—H H···A D···A D—H···A 
N1—H1···O3(A) 0.92 (2) 1.92 (2) 2.8305 (17) 168 (2) 
O3—H3···O2 0.98 (3) 1.71 (3) 2.6651 (16) 165 (2) 
Symmetry code:  (A) -x, -y+1, -z+1. 
 
The formation of the fused azetidinone product 9 was unexpected and several 
mechanisms for generation of the 4-membered lactam ring compound can be considered. 
It is not clear how the nitrogen atom of the 4-membered lactam ring was introduced into 
the molecule, or the order of the ring forming steps. The azetidinone nitrogen is most likely 
derived from the hexamethyldisilazane (HMDS) formed as a by-product during 
deprotonation. The most plausible mechanism we propose here (Scheme 2) involves 
formation of the ester enolate 10 by deprotonation of 6 with KHMDS, and reaction of the 
resulting HMDS, or the excess KHMDS, with benzil 7a to form either the mono- (7b) or bis-
imine (7c). Either electrophile could then condense with anion 10 to form the azetidinone 
derivative 11. The reaction of imines with ester enolates is a well established method to 
form medicinally important 4-membered lactams.13 Subsequent deprotonation of the 6-
methyl group of the pyridone ring would generate enolate 12, the cis diastereoisomer of 
which could undergo intramolecular aldol reaction with the ketone (X = O) or silylimine (X = 
NSiMe3) group forming 13. Subsequent elimination would then generate the observed 
product 9, which was isolated after aqueous work-up. 
 
 
Scheme 2: Possible mechanism for formation of azeto[2,3-c]quinolizine 9 
 
An initial aldol reaction occurring next to the ester group was supported by the observation 
that deprotonation of 6 with one equivalent of KHMDS and quenching with D2O at –78 °C 
led to deuterium incorporation predominantly at the methylene group of the acetate [δH 
(CD3)2SO 4.79 (s, CH2), 4.77 (bs, CHD) and δC 43.5 (CH2), 43.3 (t, JCD = 22 Hz, CHD)] 
rather than at the pyridone methyl substituent. Other pathways to give 9 can be conceived, 
and the mechanism of the reaction is under further investigation. Very few examples of 
compounds in which a β-lactam ring is fused to an otherwise unsaturated naphthalene 
type ring are known,14-17 and, to the best of our knowledge, none to an unsaturated 
heterocyclic framework. Compounds of type 9 are likely to exhibit useful biological activity, 
and further work to improve the yield and scope of this reaction is in progress.  
 
Conclusion 
 
The first example of a derivative of the tricyclic azeto[2,3-c]quinolizine-1,8-dione ring 
system has been isolated and its structure confirmed by NMR spectroscopy, mass 
spectrometry and single crystal synchrotron X-ray diffraction analysis. 
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